Fol. Biol. 2016, 62, 167-174
https://doi.org/10.14712/fb2016062040167
Comparison of the Radiosensitizing Effect of ATR, ATM and DNA-PK Kinase Inhibitors on Cervical Carcinoma Cells
Crossref Cited-by Linking
- Markovina Stephanie, Rendle Katharine A., Cohen Alexander C., Kuroki Lindsay M., Grover Surbhi, Schwarz Julie K.: Improving cervical cancer survival\u2013A multifaceted strategy to sustain progress for this global problem. Cancer 2022, 128, 4074. <https://doi.org/10.1002/cncr.34485>
- Kopa Paulina, Macieja Anna, Pastwa Elzbieta, Majsterek Ireneusz, Poplawski Tomasz: DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells. Mol Biol Rep 2021, 48, 709. <https://doi.org/10.1007/s11033-020-06124-9>
- Faulhaber Eva-Maria, Jost Tina, Symank Julia, Scheper Julian, Bürkel Felix, Fietkau Rainer, Hecht Markus, Distel Luitpold V.: Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells. Genes 2021, 12, 925. <https://doi.org/10.3390/genes12060925>
- Medová Michaela, Medo Matú\u0161, Hovhannisyan Lusine, Muñoz-Maldonado Carmen, Aebersold Daniel M., Zimmer Yitzhak: DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions. Pharmacology & Therapeutics 2020, 215, 107617. <https://doi.org/10.1016/j.pharmthera.2020.107617>
- Wong Way Wua, Jackson Rosanna K., Liew Lydia P., Dickson Benjamin D., Cheng Gary J., Lipert Barbara, Gu Yongchuan, Hunter Francis W., Wilson William R., Hay Michael P.: Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361. Biochemical Pharmacology 2019, 169, 113641. <https://doi.org/10.1016/j.bcp.2019.113641>
- Lee Tet Woo, Wong Way Wua, Dickson Benjamin D., Lipert Barbara, Cheng Gary J., Hunter Francis W., Hay Michael P., Wilson William R.: Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia. International Journal of Radiation Biology 2019, 95, 1597. <https://doi.org/10.1080/09553002.2019.1664787>
- Cossar L.H., Schache A.G., Risk J.M., Sacco J.J., Jones N.J., Lord R.: Modulating the DNA Damage Response to Improve Treatment Response in Cervical Cancer. Clinical Oncology 2017, 29, 626. <https://doi.org/10.1016/j.clon.2017.03.002>